A phase I study of accelerated radiotherapy for glioblastoma multiforme using stereotactic concomitant boosts for dose escalation

被引：0
|
作者：
Chung, T [1 ]
Wallace, T [1 ]
Cardinale, R [1 ]
Broaddus, W [1 ]
Benedict, S [1 ]
Ramekrishnan, V [1 ]
Schmidt-Ullrich, R [1 ]
机构：
[1] Virginia Commonwealth Univ, Richland, WA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2005.07.455
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2061
引用
收藏
页码：S265 / S266
页数：2
相关论文
共 50 条
  • [21] The Effect of Stereotactic Lung Radiotherapy on Pulmonary Function Tests in A Prospective Phase I/II Dose Escalation Study
    Tinger, Alfred
    Bures, Sergio
    Klares, Scott
    Goldberg, Jonathan
    Lester, Thomas
    Rummo, Nicholas
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (02): : 204 - 204
  • [22] A Phase I/II Clinical Trial of Hyperfractionated Concomitant Boost Proton Radiotherapy for Supratentorial Glioblastoma Multiforme
    Tsuboi, K.
    Mizumoto, M.
    Igaki, H.
    Yamamoto, T.
    Takano, S.
    Okumura, T.
    Sakurai, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S231 - S231
  • [23] Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme
    Ford, Judith M.
    Seiferheld, Wendy
    Alger, Jeffrey R.
    Wu, Genevieve
    Endicott, Thyra J.
    Mehta, Minesh
    Curran, Walter
    Phan, See-Chun
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : 831 - 838
  • [24] Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1)
    Massaccesi, Mariangela
    Ferro, Marica
    Cilla, Savino
    Balducci, Mario
    Deodato, Francesco
    Macchia, Gabriella
    Valentini, Vincenzo
    Morganti, Alessio G.
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (05) : 784 - 791
  • [25] Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1)
    Mariangela Massaccesi
    Marica Ferro
    Savino Cilla
    Mario Balducci
    Francesco Deodato
    Gabriella Macchia
    Vincenzo Valentini
    Alessio G. Morganti
    International Journal of Clinical Oncology, 2013, 18 : 784 - 791
  • [26] A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme
    Alonso-Basanta, Michelle
    Fang, Penny
    Maity, Amit
    Hahn, Stephen M.
    Lustig, Robert A.
    Dorsey, Jay F.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 116 (02) : 365 - 372
  • [27] A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme
    Michelle Alonso-Basanta
    Penny Fang
    Amit Maity
    Stephen M. Hahn
    Robert A. Lustig
    Jay F. Dorsey
    Journal of Neuro-Oncology, 2014, 116 : 365 - 372
  • [28] Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study
    Balducci, Mario
    Chiesa, Silvia
    Diletto, Barbara
    D'Agostino, Giuseppe Roberto
    Mangiola, Annunziato
    Manfrida, Stefania
    Mantini, Giovanna
    Albanese, Alessio
    Fiorentino, Alba
    Frascino, Vincenzo
    De Bari, Berardino
    Micciche', Francesco
    De Rose, Fiorenza
    Morganti, Alessio Giuseppe
    Anile, Carmelo
    Valentini, Vincenzo
    NEURO-ONCOLOGY, 2012, 14 (01) : 79 - 86
  • [29] Phase I dose escalation trial of image guided stereotactic body radiotherapy for lung tumors
    Feigenberg, S. J.
    Sharma, N.
    Wang, L.
    Cohen, R.
    Buyyounouski, M.
    Lally, B.
    Movsas, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S114 - S114
  • [30] RADIOTHERAPY WITH CONCOMITANT AND ADJUVANT TEMOZOLOMIDE IN GLIOBLASTOMA MULTIFORME PATIENTS: A PROSPECTIVE STUDY
    Sarihan, S.
    Yildirim, S.
    Ozturk, H.
    Evrensel, T.
    Kocaeli, H.
    Tolunay, S.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S216 - S216
12345